ovarian cancer evaluation

We’d love your feedback

HRD or HRR: That is the Question

Your valuable comments help us improve the quality of webinars and we are looking forward to hearing your thoughts. We would appreciate if you could kindly take a few minutes to answer these questions. Thank you very much.

1. Following the webinar, how confident are you in differentiating between HRD and HRR tests? *

2. How would you rate the topics and the speakers?

Overview of HRD and theories behind testing *

Up-to-date & Inspiring	Good Review	Nothing New	Not Relevant
Up-to-date & InspiringUp-to-date & Inspiring	Good ReviewGood Review	Nothing NewNothing New	Not RelevantNot Relevant

Professor Diether Lambrechts *

Excellent	Good	Average	Poor
ExcellentThe topics discussed in this meeting are relevant to my clinical practice Excellent	GoodThe topics discussed in this meeting are relevant to my clinical practice Good	AverageThe topics discussed in this meeting are relevant to my clinical practice Average	PoorThe topics discussed in this meeting are relevant to my clinical practice Poor

What’s next after HRD testing? Therapeutic implications for ovarian cancer patients *

Up-to-date & Inspiring	Good Review	Nothing New	Not Relevant
Up-to-date & InspiringUp-to-date & Inspiring	Good ReviewGood Review	Nothing NewNothing New	Not RelevantNot Relevant

Dr John Chia *

Excellent	Good	Average	Poor
ExcellentThe topics discussed in this meeting are relevant to my clinical practice Excellent	GoodThe topics discussed in this meeting are relevant to my clinical practice Good	AverageThe topics discussed in this meeting are relevant to my clinical practice Average	PoorThe topics discussed in this meeting are relevant to my clinical practice Poor

3. Which part of today’s webinar was most useful to you?

4. Any other topics / areas that you would have liked to be included?

5. What improvements can be made to the webinar?

HK-7205May 2022

HK-7205
May 2022